Oracle Named Leader in Everest Group’s 2024 PEAK Matrix® for Life Sciences CTMS

Oracle Recognized as a Leader in Everest Group’s 2024 PEAK Matrix® for Life Sciences CTMS

Oracle Life Sciences has been named a ‘Leader’ in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024, solidifying its position as a driving force in transforming clinical trial management. This recognition highlights Oracle’s commitment to delivering innovative, cost-effective solutions that address the evolving needs of healthcare systems and life sciences organizations worldwide. As clinical trials grow increasingly complex, regulatory demands rise, and the need for real-time insights becomes critical, Oracle continues to set the industry standard with its Siebel CTMS platform, empowering organizations to streamline operations, enhance compliance, and accelerate innovation.

Transforming Clinical Trials with Oracle Siebel CTMS

The life sciences industry is undergoing rapid transformation, driven by challenges such as increasing trial complexity, diverse regulatory requirements, and the growing importance of integrating multiple data sources. Oracle’s Siebel CTMS addresses these challenges head-on by providing a comprehensive solution that supports seamless integration with key clinical systems, including Electronic Health Records (EHR), Electronic Data Capture (EDC), Clinical Data Management Systems (CDMS), electronic Trial Master File (eTMF), payment systems, analytics platforms, and regulatory tools.

This robust integration ensures smooth data flow between investigators, Contract Research Organizations (CROs), sponsors, and other stakeholders, enabling real-time collaboration and decision-making. By adhering to diverse global regulatory standards, Oracle’s CTMS platform ensures compliance while maintaining flexibility to meet the unique needs of pharmaceutical companies and healthcare systems.

“Being designated as a ‘Leader’ by Everest Group in its assessment of our CTMS validates Oracle’s mission to deliver cutting-edge technology that accelerates innovation and helps improve outcomes in life sciences,” said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. “We are harnessing the full power of Oracle’s expertise in data and AI to deliver platforms like CTMS, purpose-built to address the unique challenges of pharma and healthcare systems. Our solution is compliant, secure, cost-effective, and globally adaptable, empowering organizations to drive innovation and efficiency in clinical research and care delivery.”

Why Oracle Stands Out in the CTMS Market

The Everest Group PEAK Matrix® Assessment highlights Oracle’s strengths in delivering a comprehensive solution tailored to the critical needs of clinical trial management. Key factors contributing to Oracle’s leadership position include:

  1. Global Adaptability and Compliance:
    Oracle’s Siebel CTMS platform is designed to accommodate diverse regulatory requirements across regions, ensuring consistent operations and compliance on a global scale.
  2. Competitive Pricing and Seamless Integration:
    The platform offers competitive pricing and integrates effortlessly with essential clinical systems, including EDC, CDMS, eTMF, payment solutions, analytics tools, and regulatory platforms. This seamless connectivity enhances data accuracy, reduces manual effort, and improves operational efficiency.
  3. Customization and Flexibility:
    Clients value the platform’s ability to be customized to meet specific organizational needs, making it a versatile solution for organizations of all sizes.
  4. Extensive Global Footprint:
    Oracle’s expansive global presence ensures consistent and reliable operations across regions, enabling organizations to manage multinational trials with ease.

“The CTMS market is rapidly evolving in response to growing trial complexity, the need for real-time collaboration, and the integration of diverse data sources,” said Nisarg Shah, practice director at Everest Group. “Providers are now delivering comprehensive trial data management solutions that offer enhanced features to elevate the quality of information provided.”

“Oracle’s Siebel CTMS platform offers a comprehensive, one-stop-shop solution for clinical trial management, providing flexibility for customization to meet specific organizational needs. Clients value the platform’s seamless integration with various critical clinical systems and analytics solutions. Oracle’s extensive global footprint, which helps deliver consistent operations across regions, combined with its expansive capabilities and competitive pricing, have positioned Oracle as a Leader in the Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024.”

Understanding the Everest Group PEAK Matrix® Framework

The PEAK Matrix® is a proprietary framework used by Everest Group to assess service providers based on their performance, experiences, abilities, and knowledge. Providers are evaluated on two key dimensions:

  1. Market Success:
    Measured by revenue, number of clients, and year-over-year growth.
  2. Delivery Capability:
    Assessed based on the scale of operations, scope, technology and innovation, delivery footprint, and buyer satisfaction.

Based on these evaluations, service providers are categorized as Leaders, Major Contenders, or Aspirants. Oracle’s designation as a Leader reflects its strong market presence, innovative technology, and ability to deliver exceptional value to clients in the life sciences industry.

Empowering Life Sciences Organizations with Oracle CTMS

Oracle’s Siebel CTMS platform is more than just a tool—it’s a strategic asset for life sciences organizations seeking to navigate the complexities of modern clinical trials. By combining advanced data management, AI-driven insights, and seamless integrations, Oracle empowers organizations to:

  • Accelerate clinical trial timelines through streamlined workflows and real-time collaboration.
  • Ensure compliance with global regulatory standards while reducing administrative burdens.
  • Enhance data accuracy and accessibility, enabling better decision-making and improved trial outcomes.
  • Optimize costs through competitive pricing and efficient resource utilization.

As the demand for innovative clinical trial solutions continues to grow, Oracle remains at the forefront of the industry, leveraging its expertise in data, AI, and cloud technologies to deliver platforms that drive meaningful impact.

Experience the Power of Oracle Siebel CTMS Today

To learn more about how Oracle’s Siebel CTMS can transform your clinical trial management processes, explore Oracle’s offerings and discover why it has been recognized as a Leader in the Everest Group PEAK Matrix® Assessment 2024. With its unmatched capabilities, global adaptability, and commitment to innovation, Oracle is the ideal partner for organizations looking to excel in clinical research and care delivery.

Stay ahead of the curve and unlock new levels of efficiency, compliance, and innovation in your clinical trials with Oracle’s cutting-edge CTMS platform. Empower your organization to thrive in today’s dynamic life sciences landscape by partnering with a proven leader in clinical trial management.

Source link

Share your love